GT Biopharma, Inc. held its annual stockholder meeting on July 24, 2025, where 1,855,160 of 3,147,995 shares voted on key proposals, including the election of board members and financial approvals. Notably, the proposal to increase shares for the incentive plan was approved with 1,151,610 votes in favor.